Brief: US Court Denies 'Motion To Dismiss' From Xspray Pharma In Patent Dispute

Xspray Pharma publ AB

26/04/2023 08:43

April 26 (Reuters) - XSpray Pharma AB (publ)  XSPRAY.ST :
    * RECEIVES EXPECTED PARTIAL DECISION IN PATENT CASE REGARDING MATTER OF LAW
    * UNITED STATES DISTRICT COURT HAS DECIDED TO DENY "MOTION TO DISMISS" FROM XSPRAY PHARMA IN
COMPANY'S ONGOING PATENT DISPUTE
    * RULING MEANS THAT COUNTER PARTY IS ALLOWED TO PURSUE CASE FURTHER
    * DISPUTE CONCERNS A PATENTED CRYSTALLINE SUBSTANCE THAT HAS NO PRESENCE IN XSPRAY PHARMA'S
PRODUCT CANDIDATE
    * COMPANY CONTINUES TO PLAN FOR US LAUNCH OF PRODUCT CANDIDATE XS004 TO TAKE PLACE IN SECOND
HALF
OF 2023 OR ALTERNATIVELY BEFORE JULY 2024

Source text for Eikon:  ID:nMFN7hX3ml 
Further company coverage:  XSPRAY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))